91 related articles for article (PubMed ID: 3130180)
1. Efficacy of follow-up bone scans in carcinoma of the prostate.
Corrie D; Timmons JH; Bauman JM; Thompson IM
Cancer; 1988 Jun; 61(12):2453-4. PubMed ID: 3130180
[TBL] [Abstract][Full Text] [Related]
2. The role of routine followup bone scans after definitive therapy of localized prostatic cancer.
Huben RP; Schellhammer PF
J Urol; 1982 Sep; 128(3):510-2. PubMed ID: 6214643
[TBL] [Abstract][Full Text] [Related]
3. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
4. The benefits of combining early radionuclide renal scintigraphy with routine bone scans in patients with prostate cancer.
Narayan P; Lillian D; Hellstrom W; Hedgcock M; Jajodia PB; Tanagho EA
J Urol; 1988 Dec; 140(6):1448-51. PubMed ID: 3057227
[TBL] [Abstract][Full Text] [Related]
5. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
[TBL] [Abstract][Full Text] [Related]
6. [Value of bone gammagraphy and pain in the follow-up of carcinoma of the prostate].
Ruiz Cerdá JL; Llopis Minguez B; Server Pastor G; Vidal Moreno JF; Boronat Tormo F; Jiménez Cruz JF
Arch Esp Urol; 1989; 42 Suppl 2():206-8. PubMed ID: 2639624
[TBL] [Abstract][Full Text] [Related]
7. [The role of bone scintigraphy and its value in the staging and follow up of prostatic carcinoma].
Adám E; Gervain M; Rajtár M; Oszlánczi J; Csernay L; Scultéty S
Orv Hetil; 1989 Feb; 130(7):335-40. PubMed ID: 2645558
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of preoperative ProstaScint scans in the prediction of nodal disease.
Ponsky LE; Cherullo EE; Starkey R; Nelson D; Neumann D; Zippe CD
Prostate Cancer Prostatic Dis; 2002; 5(2):132-5. PubMed ID: 12497003
[TBL] [Abstract][Full Text] [Related]
9. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.
Soloway MS; Hardeman SW; Hickey D; Raymond J; Todd B; Soloway S; Moinuddin M
Cancer; 1988 Jan; 61(1):195-202. PubMed ID: 3334948
[TBL] [Abstract][Full Text] [Related]
10. Capromab Pendetide imaging of prostate cancer.
Haseman MK; Rosenthal SA; Polascik TJ
Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
[TBL] [Abstract][Full Text] [Related]
11. Development of monoclonal antibody imaging of metastatic prostatic carcinoma.
Meyers FJ; Denardo SJ; Macey D; White RD; Unger M
Prostate; 1989; 14(3):209-20. PubMed ID: 2471962
[TBL] [Abstract][Full Text] [Related]
12. [Staging of patients with carcinoma of the breast by bone scans? [author's transl)].
Creutzig H
Radiologe; 1978 May; 18(5):179-83. PubMed ID: 652985
[TBL] [Abstract][Full Text] [Related]
13. A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer.
Reza M; Kaboteh R; Sadik M; Bjartell A; Wollmer P; Trägårdh E
BMC Med Imaging; 2018 May; 18(1):8. PubMed ID: 29728144
[TBL] [Abstract][Full Text] [Related]
14. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
[TBL] [Abstract][Full Text] [Related]
15. Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma.
Kane RD; Paulson DF
J Urol; 1977 May; 117(5):618-21. PubMed ID: 859203
[TBL] [Abstract][Full Text] [Related]
16. Utilization of bone scans in conjunction with prostate-specific antigen levels in the surveillance for recurrence of adenocarcinoma after radical prostatectomy.
Terris MK; Klonecke AS; McDougall IR; Stamey TA
J Nucl Med; 1991 Sep; 32(9):1713-7. PubMed ID: 1715394
[TBL] [Abstract][Full Text] [Related]
17. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.
Al-Ghazo MA; Ghalayini IF; Al-Azab RS; Bani-Hani I; Barham A; Haddad Y
Int Braz J Urol; 2010; 36(6):685-91; discussion 691-2. PubMed ID: 21176275
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
[TBL] [Abstract][Full Text] [Related]
20. [Carcinoma of the prostate: correlation between local staging and systemic progression].
Rosi P; Marzi M; Mearini E; Bracarda S; Valli PP; Petroni PA; Porena M
Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):91-5. PubMed ID: 9162385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
